- Home
- ENTA vs ONEG Comparison
ENTA vs ONEG Comparison
Compare ENTA & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTA
- ONEG
- Stock Information
- Founded
- ENTA 1995
- ONEG 2021
- Country
- ENTA United States
- ONEG Hong Kong
- Employees
- ENTA N/A
- ONEG N/A
- Industry
- ENTA Biotechnology: Pharmaceutical Preparations
- ONEG Homebuilding
- Sector
- ENTA Health Care
- ONEG Consumer Discretionary
- Exchange
- ENTA Nasdaq
- ONEG Nasdaq
- Market Cap
- ENTA 164.6M
- ONEG 181.8M
- IPO Year
- ENTA 2013
- ONEG 2024
- Fundamental
- Price
- ENTA $11.81
- ONEG $11.33
- Analyst Decision
- ENTA Strong Buy
- ONEG
- Analyst Count
- ENTA 5
- ONEG 0
- Target Price
- ENTA $20.20
- ONEG N/A
- AVG Volume (30 Days)
- ENTA 1.1M
- ONEG 283.0K
- Earning Date
- ENTA 08-11-2025
- ONEG 01-01-0001
- Dividend Yield
- ENTA N/A
- ONEG N/A
- EPS Growth
- ENTA N/A
- ONEG N/A
- EPS
- ENTA N/A
- ONEG 0.08
- Revenue
- ENTA $64,806,000.00
- ONEG $53,205,000.00
- Revenue This Year
- ENTA N/A
- ONEG N/A
- Revenue Next Year
- ENTA $1.65
- ONEG N/A
- P/E Ratio
- ENTA N/A
- ONEG $147.84
- Revenue Growth
- ENTA N/A
- ONEG N/A
- 52 Week Low
- ENTA $4.09
- ONEG $1.48
- 52 Week High
- ENTA $15.28
- ONEG $13.50
- Technical
- Relative Strength Index (RSI)
- ENTA 61.09
- ONEG 50.38
- Support Level
- ENTA $7.05
- ONEG $10.91
- Resistance Level
- ENTA $15.34
- ONEG $11.82
- Average True Range (ATR)
- ENTA 1.32
- ONEG 0.79
- MACD
- ENTA 0.47
- ONEG -0.29
- Stochastic Oscillator
- ENTA 53.86
- ONEG 41.81
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.